| Sources | Names Used |
|---|---|
| CTRPv2 | compound 1B |
| PharmacoGx | compound 1B |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | APBA2 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | FRMPD3 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | GALNT9 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | TCEB2 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | PPM1K | CTRPv2 | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | TMEM248 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | MT2A | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | DUSP3 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | PGM5 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | TMEM170A | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
